頭蛋白(NOG)多克隆抗體
Polyclonal Antibody to Noggin (NOG)
SYM1; SYNS1; Synostoses(Multiple)Syndrome 1; Symphalangism 1(Proximal)
- 編號UPAC130Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPC130Hu01-頭蛋白(NOG)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度0.48mg/mL
- 且適物種-
- 應(yīng)用IHC
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 315 ¥ 735 ¥ 1050 ¥ 2625 ¥ 10500
- 欲了解實(shí)際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Samples: Human Placenta Tissue; Primary Ab: 20μg/ml Rabbit Anti-Human NOG Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
DAB staining on IHC-P;
Samples: Human Kidney Tissue;
Primary Ab: 20μg/ml Rabbit Anti-Human NOG Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
DAB staining on IHC-P;
Samples: Human Small intestine Tissue;
Primary Ab: 20μg/ml Rabbit Anti-Human NOG Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant NOG, Human.
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對NOG的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別NOG。
用法
Western blotting: 0.01-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長臂生物素標(biāo)記試劑盒
實(shí)時熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| UAPC130Hu01 | 頭蛋白(NOG)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPC130Hu01 | 頭蛋白(NOG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPC130Hu02 | 頭蛋白(NOG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPC130Hu61 | 頭蛋白(NOG)活性蛋白 | Cell?culture;?Activity?Assays. |
| UEPC130Hu61 | 頭蛋白(NOG)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAC130Hu01 | 頭蛋白(NOG)多克隆抗體 | IHC |
| UPAC130Hu02 | 頭蛋白(NOG)多克隆抗體 | Testing in progress |
| ULAC130Hu71 | 頭蛋白(NOG)多克隆抗體(生物素標(biāo)記) | WB |
| ULAC130Hu81 | 頭蛋白(NOG)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| UMAC130Hu21 | 頭蛋白(NOG)單克隆抗體 | WB |
| UMAC130Hu22 | 頭蛋白(NOG)單克隆抗體 | IHC |
| UMAC130Hu24 | 頭蛋白(NOG)單克隆抗體 | WB; IHC |
| UMAC130Hu26 | 頭蛋白(NOG)單克隆抗體 | WB; IHC |
| UFAC130Hu02 | 抗頭蛋白(NOG)單克隆抗體 | FCM |
| ULAC130Hu76 | 頭蛋白(NOG)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| USEC130Hu | 頭蛋白(NOG)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMC130Hu | 頭蛋白(NOG)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UPSC130Hu01 | 頭蛋白(NOG)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| UKSC130Hu01 | 頭蛋白(NOG)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Arthritis Rheumatol | Imbalance between BMP2 and Noggin induces abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis [PubMed: 26413886] |
| Arthritis Rheumatol.? | Imbalance Between Bone Morphogenetic Protein 2 and Noggin Induces Abnormal Osteogenic Differentiation of Mesenchymal Stem Cells in Ankylosing Spondylitis [Pubmed:26413886] |
| Clin Exp Pharmacol Physiol. | Oxygen-glucose deprivation preconditioning protects neurons against oxygen-glucose deprivation/reperfusion induced injury via bone morphogenetic protein-7 mediated ERK, p38 and Smad signalling pathways. [Pubmed:26385023] |
| European cells & materials | The BMP2 variant L51P restores the osteogenic differentiation of human mesenchymal stromal cells in the presence of intervertebral disc cells. [pubmed:28266688] |
| Arthritis?&?Rheumatology | mbalance?Between?Bone?Morphogenetic?Protein?2?and?Noggin?Induces?Abnormal?OsteogenicDifferentiation?of?Mesenchymal?Stem Cells in Ankylosing Spondylitis. [pubmed:26413886] |
| Biotechnology and?Applied?Biochemistry | The BMP antagonist Noggin is produced by osteoblasts in response to the presence of prostate cancer cells. [pubmed:28981962] |
| Heliyon | Efficient in vitro delivery of Noggin siRNA enhances osteoblastogenesis [pubmed:29167826] |
| Journal of Cellular Biochemistry | Low‐intensity pulsed ultrasound promotes bone morphogenic protein 9‐induced osteogenesis and suppresses inhibitory effects of inflammatory cytokines on cellular?… [Pubmed: 31006911] |
| Aging Male | Effect of tadalafil on penile nitric oxide synthase and corporal smooth muscle in rats under dutasteride treatment [Pubmed: 32160825] |
| J Reconstr Microsurg | Effect of Simvastatin Use in Free Tissue Transfer: An Experimental Study in a Rat Epigastric Free Flap Model [Pubmed: 31995818] |
| Biochem Biophys Rep | Slow diffusion on the monolayer culture enhances auto/paracrine effects of Noggin in differentiation of human iPS cells induced by BMP [Pubmed:35005256] |
